Dr Reddys announces commercial launch of DRDO’s anti-covid drug 2-DG; Here are its price and availability

DRDO DRL

The drug, 2-DB will be sold commercially under the brands 2DGTM. (IE Imagae) Hyderabad-based Dr Reddy’s Laboratory announced the commercial launch of the anti-Covid-19 drug, 2-Deoxy-D-Glucose (2-DG) for hospitalized moderate to severe Covid-19 patients. The anti-Covid therapeutic application of 2-DG has been jointly developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence … Read more

DRDO responds to questions on 2-DG’s efficacy; Also launches Antibody Detection Kit for COVID-19

1 417

It went on to state the molecule was working effectively against SARS-CoV-2 virus, and inhibited the viral growth. Last May, Drugs Controller General of India’s (DCGI) and Central Drugs Standard Control Organization (CDSCO) had approved the Phase-II clinical trial of 2-DG in COVID-19 patients. (Photo Credit : DRDO) Amidst debate over the efficacy of the … Read more